New from #StemCellEvidence: Peripheral Blood or Bone Marrow Grafts for Mismatched Unrelated Donors with Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis by Arcuri et al. www.stemcellevidence.com/articles/410... #MedSky

The #StemCellEvidence monthly alert is out! See all the top 10 articles here: www.stemcellevidence.com/alerts/latest Each one has an easy-to-read PICO summary. #MedSky

From the #StemCellEvidence Alert: Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia (...) by Ru et al. www.stemcellevidence.com/articles/409... #MedSky

New from #StemCellEvidence: Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCT by Toya et al. www.stemcellevidence.com/articles/407... #MedSky

Thank you so much @isbt.bsky.social! We are so delighted to receive this award! www.systematicreviewinitiative.com/news/we-have... @ericawood.bsky.social @liseestcourt.bsky.social @thrinaline.bsky.social

New from #StemCellEvidence: Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation by Lee et al. www.stemcellevidence.com/articles/409... #MedSky

From the #StemCellEvidence Alert: Serologic Characteristics and Clinical Significance of Non-ABO Red Blood Cell Antibodies in Hematopoietic Stem Cell Transplant. The BEST Collaborative Study by Kogler et al. www.stemcellevidence.com/articles/409... #MedSky

we have been hard at work for almost a year now on this series about the world's largest annual scavenger hunt maybe give the trailer a watch and if u dig it you can watch on Nebula starting November 5!

I made a detailed explainer video (with Q&A) for the proposed new junction in Abingdon to prioritise walking, cycling, wheeling, and generally make it a more pleasant town centre It won't work on the hardcore antis but I couldn't bear the lies going around! youtu.be/9k4VjunZhqQ?...

From the #StemCellEvidence Alert: Neurological manifestations of chronic graft versus host disease by Koren et al. www.stemcellevidence.com/articles/408... #MedSky

From the #StemCellEvidence Alert: Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial by Stelljes et al. www.stemcellevidence.com/articles/407... #MedSky

New from #StemCellEvidence: Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party by Berning et al. www.stemcellevidence.com/articles/408... #MedSky

From the #StemCellEvidence Alert: Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers by Caballero-Velázquez et al. www.stemcellevidence.com/articles/407... #MedSky

From the #StemCellEvidence Alert: Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood (...) by Capes et al. www.stemcellevidence.com/articles/407... #MedSky

New from #StemCellEvidence: Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT by Hernández-Boluda et al. www.stemcellevidence.com/articles/408... #MedSky

New from the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025 The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A #SystematicReview and #MetaAnalysis by Chen et al. www.stemcellevidence.com/articles/387... #MedSky

From the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025 Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa (...) by Garcia-Manero et al. www.transfusionevidencelibrary.com/articles/403... #MedSky

From the #StemCellEvidence Alert: Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study by Zeiser et al. www.stemcellevidence.com/articles/405... #MedSky

New from #StemCellEvidence: Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis by Perales et al. www.stemcellevidence.com/articles/406... #MedSky

From the #StemCellEvidence Alert: Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center By Oran et al. www.stemcellevidence.com/articles/407... #MedSky

New from #StemCellEvidence: Phase I/II clinical trial on the safety and preliminary efficacy of donor-derived anti-leukemia cytotoxic T lymphocytes for the prevention of leukemia relapse (...) by Montagna et al. www.stemcellevidence.com/articles/405... #MedSky

New from #StemCellEvidence: A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept by Koura et al. www.stemcellevidence.com/articles/405... #MedSky

New from #Transfusion Evidence Library: Blood-storage duration affects hematological and metabolic profiles in patients with sickle cell disease receiving transfusions by Karafin et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky

From the #Transfusion Evidence Alert: Efficacy and safety of #tranexamicacid administration for subarachnoid hemorrhage: a #systematicreview and #meta-analysis by Imai et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky

New from #StemCellEvidence: Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMT by Giebel et al. www.stemcellevidence.com/articles/406... #MedSky

From the #StemCellEvidence Alert: Bronchiectasis after allogeneic hematopoietic cell transplantation - an underdiagnosed complication by Freund et al. www.stemcellevidence.com/alerts/artic... #MedSky

The evidence is clear - 20mph zones save lives. In London, they’ve cut deaths and serious injuries by 34% and child fatalities by 75%. That's why we need to see more 20mph areas. www.theguardian.com/commentisfre...

New from #StemCellEvidence: Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL study by Cavallaro et al. www.stemcellevidence.com/alerts/artic... #MedSky

Anyone who’s paid this even *minimal* attention can tell you no, there won’t be Berlin-London direct trains Köln, Frankfurt perhaps It’s your JOB AS JOURNALISTS TO CHECK STUFF LIKE THIS Especially if you’re the transport correspondent 😡 www.theguardian.com/uk-news/2025...

From the #StemCellEvidence Alert: Phase 1/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCT by Schulz et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Effect of genetic mutations on outcomes of stem cell transplantation in children with hemophagocytic lymphohistiocytosis by Öztürk et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence: Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A report from the CIBMTR by Spellman et al. www.stemcellevidence.com/alerts/artic...

New from #StemCellEvidence: Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A report from the CIBMTR by Spellman et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis by Mehta et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence: Feasibility and efficacy of partial replacement of post transplantation cyclophosphamide with bendamustine on day +4 for graft versus host disease prophylaxis (...) by Nair et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD by Habenicht et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Monogenic Inflammatory Bowel Disease by Baccarella et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence Comparison of Chimerism Kinetics and Associated Outcomes in Patients Receiving Post-Transplant Cyclophosphamide Versus Methotrexate based GVHD Prophylaxis Following Allogeneic Hematopoietic Cell Transplant by Baranwal et al www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study (...) by Chalandon et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence: Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT by Kawamura et al. www.stemcellevidence.com/alerts/artic... #MedSky

Play Snake, the Jet Lag edition, now

New report from @rcphysicians.bsky.social couldn’t be clearer on the urgent need to clean up the UK’s air. “Air pollution remains the most important environmental threat to health, with impacts throughout the life course” - Prof Chris Whitty

New from the #StemCellEvidence Alert: Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A #systematicreview and #metaanalysis by Sureda et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from the #StemCellEvidence Alert: Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantation by Nurse et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: The Impact of Melphalan Conditioning and CD34+ Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis by Muchtar et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from the #StemCellEvidence Alert: Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis (...) by Michonneau et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV (...) by Martínez et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from the #StemCellEvidence Alert: GvHD prophylaxis with tacrolimus, sirolimus, and mycophenolate mofetil after reduced intensity conditioning hematopoietic stem cell allogeneic transplantation by Lopez-Corral et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from the #Transfusion Evidence Alert: Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial by Anker et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky